Systematic review reveals garlic supplementation suppresses nonalcoholic fatty liver disease in preclinical animal models, highlighting its potential therapeutic role in metabolic disorders.
Background: Non-alcoholic fatty liver disease (NAFLD) is considered as the most widely recognized incessant liver problem. It is accepted to be the hepatic segment of the metabolic disorder. Numerous treatment approaches have been proposed, the most encouraging of which are those with way of life interventions. This preclinical review was performed due to lack of articles on human subject during the literature search. This systematic review will help to explore basic concepts about the mechanisms by which garlic supplementation suppresses NAFLD.
No takes yet. Share an insight, caveat, or question.
Fetene et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: